Talphera (TLPH) Cost of Revenue (2016 - 2023)
Talphera's (TLPH) quarterly Cost of Revenue came in at $711000.0 in Q1 2023, up 71.74% year-on-year from $414000.0 in Q1 2022, and down 45.35% quarter-over-quarter from $1.3 million in Q4 2022.
Talphera (TLPH) Cost of Revenue (2016 - 2023) Analysis & Trends
Talphera's Cost of Revenue history runs 8 years deep, the most recent figure standing at $711000.0 for Q1 2023.
- On a quarterly basis, Cost of Revenue rose 71.74% year-over-year to $711000.0 in Q1 2023; TTM through Mar 2024 was $711000.0, a 75.38% decrease from a year earlier, with the FY2022 full-year figure at $2.6 million, down 30.96% from the prior year.
- Cost of Revenue eased to $711000.0 in Q1 2023 per TLPH's latest filing, from $1.3 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $2.1 million in Q3 2019 and bottomed at $338000.0 in Q3 2022.
- The 5-year median for Cost of Revenue is $1.2 million (2021), against an average of $1.2 million.
- Across the five-year window, Cost of Revenue jumped 145.49% in 2019 and plunged 76.28% in 2021, its largest moves.
- Year by year, Cost of Revenue stood at $1.6 million in 2019, then retreated by 19.65% to $1.3 million in 2020, then dropped by 5.08% to $1.2 million in 2021, then grew by 5.43% to $1.3 million in 2022, then tumbled by 45.35% to $711000.0 in 2023.
- Per Business Quant, the three latest TLPH Cost of Revenue figures stand at $711000.0 (Q1 2023), $1.3 million (Q4 2022), and $338000.0 (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Talphera | 87.63 Mn | 87.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 711,000.00 |
| Mar 31, 2023 | 711,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 338,000.00 |
| Sep 30, 2022 | 338,000.00 |
| Jun 30, 2022 | 538,000.00 |
| Jun 30, 2022 | 538,000.00 |
| Mar 31, 2022 | 414,000.00 |
| Mar 31, 2022 | 414,000.00 |
| Dec 31, 2021 | 1.23 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 439,000.00 |
| Sep 30, 2021 | 439,000.00 |
| Jun 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 1.04 Mn |
| Mar 31, 2021 | 1.04 Mn |
| Dec 31, 2020 | 1.30 Mn |
| Dec 31, 2020 | 1.30 Mn |